The polymorphisms within the FTO gene play an important role in the genetic determination of body weight and body mass index and have been associated with cardiovascular disease, but the causal mechanism is still a matter of debate. The possible effect on the platelet count as a marker of hemocoagulation status as a possible cardiovascular risk factor was suggested in Japanese population. We have analyzed both rs1558902 FTO polymorphism (T > A) and platelet counts in the Prague Pre and Post Menopausal Females (3PMFs) study, including those of 669 women (mean age, 55.7 ± 2.7 years). The frequencies of the FTO genotypes were similar to other populations (TT, 30.4%; TA, 48.1%; and AA, 21.5%). We have not detected a significant association between the FTO rs1558902 variant and platelet counts in white women (TT, 242 ± 55 × 109; TA, 246 ± 67 × 109; and AA, 247 ± 55 × 109; F[2.642] = 0.30, P = 0.75). At least in white persons, platelet count seems not to be a link between the FTO variation and risk of cardiovascular disease.
AngelopoulosTJ, LowndesJ.ApoE genotype: impact on health, fitness and nutrition. World Rev Nutr Diet. 2008; 98: 77–93.
2.
PoledneR, HubacekJA, StanekV, . Why we are not able to find the coronary heart disease gene—apoE as an example. Fol Biol. 2010; 56: 218–222.
3.
HubacekJA, AdamkovaV, VrablikM, . Apolipoprotein A5 in health and disease. Physiol Res. 2009; 58: 101–109.
4.
FawcettKA, BarrosoI.The genetics of obesity: FTO leads the way. Trends Genet. 2010; 26: 266–274.
5.
DoneyAS, DannfaldJ, KimberCH, . The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research study in Tayside Scotland (Go-DARTS) study. Circ Cardiovasc Genet. 2009; 2: 255–259.
6.
HubacekJA, StanekV, GebauerovaM, . FTO variant and risk of acute coronary syndrome. Clin Chim Acta. 2010; 411: 1069–1072.
7.
ScottLJ, MohlkeKL, BonnycastleLL, . A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007; 316: 1341–1345.
8.
NockNL, PlummerSJ, ThompsonCL, . FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis. 2011; 32: 748–756.
9.
JiaG, YangCG, YangS, . Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 2008; 582: 3313–3319.
10.
WuQ, SaundersRA, Szkudlarek-MikhoM, . The obesity-associated Fto gene is a transcriptional coactivator. Biochem Biophys Res Commun. 2010; 401: 390–395.
11.
KotaniK, FujiwaraS, TsuzakiK, . FTO gene polymorphisms and platelet counts in a general Japanese population. J Invest Med. 2012; 60: 514–516.
12.
MunafòMR.Reliability and replicability of genetic association studies. Addiction. 2009; 104: 1439–1440.
13.
HubacekJA, PithaJ, AdamkovaV, . A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies. Clin Chem Lab Med. 2009; 47: 387–390.
14.
MillerSA, DykesDD, PoleskyHF.A simple salting out procedure for DNA extraction from human nucleated cells. Nucleic Acid Res. 1988; 16: 1215.
15.
HubacekJA, BohuslavovaR, KuthanovaL, . The FTO gene and obesity in a large Eastern European population sample: the HAPIEE study. Obesity. 2008; 16: 2764–2766.
16.
FraylingTM, TimpsonNJ, WeedonMN, . A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316: 889–894.
17.
DinaC, MeyreD, GallinaS, . Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007; 39: 724–726.
18.
LegryV, CottelD, FerrièresJ, . Effect of an FTO polymorphism on fat mass, obesity, and type 2 diabetes mellitus in the French MONICA Study. Metabolism. 2009; 58: 971–975.
19.
HubacekJA, ViklickyO, DlouhaD, . The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population. Nephrol Dial Transplant. 2012; 27: 1030–1035.
20.
BrennanP, McKayJ, MooreL, . Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol. 2009; 38: 971–975.
21.
HubacekJA, DlouhaD, BobakM, . The risk of sporadic colorectal cancer development is not influenced by fat mass and obesity related gene polymorphism in Slavs. Eur J Intern Med. 2012; 23: e175–e176.
22.
ZimmermannE, KringSI, BerentzenTL, . Fatness-associated FTO gene variant increases mortality independent of fatness - in cohorts of Danish men. PLoS One. 2009; 4: e4428.
23.
DlouhaD, SuchanekP, LanskaV, . Body mass index change in females after short-time life style intervention is not dependent on the FTO polymorphisms. Physiol Res. 2011; 60: 199–202.
24.
HubacekJA, PikhartH, PeaseyA, . FTO variant, energy intake, physical activity and basal metabolic rate in Caucasians. The HAPIEE study. Physiol Res. 2011; 60: 175–183.
25.
DlouhaD, PithaJ, LanskaV, . Association between FTO 1st intron tagging variant and telomere length in middle aged females. 3PMFs study. Clin Chim Acta. 2012; 41: 1222–1225.
